Know Cancer

or
forgot password
  • cancer clinical trials in new york, NY

  • Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
    Mount Sinai Hospital

    Trial Locations
    Mount Sinai Hospital
    Cornell University Medical College
    Critically Ill, Hyperglycemia
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    Beth Israel Medical Center - Petrie Division
    St. Luke's - Roosevelt Hospital Center - St.Luke's Division
    Esophageal Cancer
    Correlative Biomarker Study in Patients With Myeloproliferative Disorders
    Icahn School of Medicine at Mount Sinai
    New York, New York 10029
    Myeloproliferative Disease, Myelofibrosis, Idiopathic Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Research Tissue Bank
    Mount Sinai Medical Center
    New York, New York 10029
    Myelofibrosis, Idiopathic Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
    Memorial Sloan Kettering Cancer Center

    Trial Locations
    Memorial Sloan Kettering Cancer Center
    Weill Cornell Medical Center
    Hodgkin's Disease, Lymphoma
    Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Leukemia, Myelodysplastic Syndrome
    Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Thyroid Cancer
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    New York, New York 10032
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression
    Columbia Presbyterian Hospital
    New York, New York 10032
    Breast Cancer
    An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
    New York University Cancer Center
    New York, New York 10016
    Mesothelioma
    A Study to Evaluate the Use of the Drug Combination Vorinostat, Niacinamide, and Etoposide in Patients With Lymphoid Malignancies That Have Reoccurred
    Columbia University Medical Center
    New York, New York 10032
    Hodgkin's Disease, Non-Hodgkin's Lymphoma
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Weill Medical College of Cornell University
    New York, New York 10021
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Aids-related Malignancies, Lymphoma, Precancerous Condition, Sarcoma
    Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
    New York University Cancer Center

    Trial Locations
    New York University Cancer Center
    Bellevue Hospital
    Pancreatic Cancer
    Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Hodgkin's Disease, Lymphoma
    A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Uterine Cancer, Cervix Uteri Nos, Gestational Trophoblastic Disease
    Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC
    GSK Investigational Site
    New York, New York 10021
    Neoplasms, Breast
    The Sexual Health of Rectal Cancer Patients
    Memorial Sloan-Kettering Cancer Center

    Trial Locations
    Memorial Sloan-Kettering Cancer Center
    Mount Sinai Hospital
    Rectal Cancer, Rectum
    Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Mesothelioma
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    New York, New York 10032
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Physical Activity Intervention for Lung Cancer Survivors
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Lung Cancer, Survivor
    Efficacy and Safety of Nilotinib Patients With Newly Diagnosed CML - CP (Chronic Myelogenous Leukemia - Chronic Phase)
    Memorial Sloan Kettering Cancer Center Clinical Trials Office
    New York, New York 10021
    Myelogenous Leukemia, Chronic
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Weill Medical College of Cornell University

    Trial Locations
    Weill Medical College of Cornell University
    New York University Langone Medical Center
    Columbia University Medical Center
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Recurrent Endometrial Carcinoma
    Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
    New York Weill Cornell Cancer Center at Cornell University
    New York, New York 10021
    Breast Cancer
    Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia
    GSK Investigational Site
    New York, New York 10021
    WT1-positive Acute Myeloid Leukemia, Leukaemia, Myelocytic, Acute
    The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
    Mount Sinai Medical Center

    Trial Locations
    Mount Sinai Medical Center
    NYU Langone Medical Center
    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma, Sarcoma, Neuroblastoma
    Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Recurrent Thyroid Cancer, Stage III Follicular Thyroid Cancer, Stage III Papillary Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
    Memorial Sloan Kettering Cancer Center
    New York, New York 10021
    Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    Mount Sinai School of Medicine
    New York, New York 10029
    Primary Progressive Multiple Sclerosis
    Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
    NYU Cancer Institute at New York University Medical Center
    New York, New York 10016
    Pancreatic Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Mount Sinai Medical Center

    Trial Locations
    Mount Sinai Medical Center
    Columbia University Medical Center
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    An Efficacy Study of MORAb-009 Amatuximab in Subjects With Pleural Mesothelioma
    Columbia University Medical Center
    New York, New York 10032
    Malignant Pleural Mesothelioma
    Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
    Memorial Sloan-Kettering Cancer Center
    New York, New York 10021
    Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma, Chronic Myelogenous Leukemia
    MLN8237 in Young Patients With Relapsed or Refractory Solid Tumors or Acute Lymphoblastic Leukemia
    Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center
    New York, New York 10032
    Leukemia, Neuroblastoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer
    Beth Israel
    New York, New York 10003
    Breast Cancer, Carcinoma, Lumpectomy, Ductal Carcinoma in Situ
    A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma
    Site Reference ID/Investigator# 63585
    New York, New York 10029
    Hematologic Cancer
    Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
    Mount Sinai Medical Center
    New York, New York 10029
    Multiple Myeloma and Plasma Cell Neoplasm